JANX icon

Janux Therapeutics

155 hedge funds and large institutions have $1.87B invested in Janux Therapeutics in 2024 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

4.3% more ownership

Funds ownership: 81.95%86.26% (+4.3%)

8% less call options, than puts

Call options by funds: $4.12M | Put options by funds: $4.46M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
155
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.12M
Puts
$4.46M
Net Calls
Net Calls Change

Top Buyers

1 +$65.5M
2 +$61.6M
3 +$42M
4
VPC
Vestal Point Capital
New York
+$30.4M
5
BlackRock
BlackRock
New York
+$27.2M

Top Sellers

1 -$104M
2 -$54.3M
3 -$37.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$33.2M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$18.8M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$817K
77
$808K
78
$805K
79
$758K
80
$685K
81
$653K
82
$632K
83
$603K
84
$598K
85
$520K
86
$512K
87
$484K
88
$484K
89
$483K
90
$477K
91
$458K
92
$425K
93
$420K
94
$418K
95
$407K
96
$406K
97
$404K
98
$398K
99
$377K
100
$375K